ROBERTO PILI joined the Indiana University Melvin and Bren Simon Cancer Center. Pili will direct the genitourinary research program at the cancer center and serve as the medical director of the genitourinary clinical program at the IU Health Simon Cancer Center.
A group of melanoma experts, joined by three advocacy groups focused on melanoma, has engaged FDA in a public discussion of the challenges of developing new drugs in the refractory setting and the role crossover can play in such trials.
